Blog

Braskem, a market leader in the production of biopolymers on an industrial scale, is currently at K 2025, the world’s leading trade fair for plastics and rubber in D



üsseldorf, Germany. On the opening day, Braskem showcased a new generation of bio-based and circular product solutions aimed at accelerating the transformation of the plastics industry. Under its sustainable portfolio, Braskem is revealing product launches and partnerships that bring sustainability and innovation to life across packaging, healthcare, hygiene, and consumer goods.

“K 2025 is the ideal platform to show how our innovations are ready for real-world application,” said Walmir Soller, VP Olefins/Polyolefins North America, Europe, and Asia. “We’re not just testing the market; we’re scaling up solutions that combine technical performance with environmental benefits.”

New product launches

MDO film with I’m green^TM



 bio-based PE

Braskem introduces a new application of Machine Direction-Oriented (MDO) technology using bio-based polyethylene derived from ethanol, made with sugarcane. These films deliver enhanced stiffness, optical properties, and recyclability, enabling mono-material packaging such as flow packs, MDO labels, and stand-up pouches. The use of MDO films enables the development of structures that are more aligned with the circular economy, while still meeting performance requirements. The MDO films are developed in collaboration with Cazoolo, Braskem’s circular packaging design lab, and converter FCO Group.

Medcol: I’m green^TM



 bio-based LDPE for healthcare

Under the Medcol brand, Braskem presents a low-density polyethylene designed for pharmaceutical applications such as blow-fill-seal processes, like plastic ampoules with twist-off caps. The material meets regulatory requirements without additives and offers improved temperature resistance and flowability. Its updated Life Cycle Assessment study (2023) shows a carbon footprint of -2.27 kgCO



²e per kg, reinforcing its sustainability profile within healthcare packaging.

I’m green^TM



 bio-based HDPE for non-wovens

Braskem introduces the I’m green^TM bio-based high-density polyethylene specifically developed for the non-wovens market. Designed for hygiene and bi-component fiber applications such as diapers, this HDPE offers low gel levels, excellent processing stability, improved heat resistance, and great color stability. It performs well in both bi-component spunbond and mono-component spunbound processes, ensuring reliability in high-performance hygiene applications. According to a 2023 updated Life Cycle Assessment study, the material has a carbon footprint of -2.01 kgCO



²e per kg, underscoring its contribution to more sustainable hygiene product solutions.

EVA 21%: ultra-soft I’m green^TM



 bio-based foam

Braskem presents a new I’m green^TM bio-based ethylene-vinyl acetate (EVA) containing 21% vinyl acetate, offering significantly improved softness and flexibility compared to lower VA grades. This material is particularly well-suited for footwear applications, especially soles and insoles that require enhanced comfort and performance. As part of Braskem’s I’m greenT bio-based portfolio, this EVA combines functional advantages with a renewable origin, making it a sustainable alternative for high-quality consumer goods.

Featured applications at the booth

Polytan: a leading German manufacturer of high-performance sports surfaces, is using Braskem’s I’m green^TM



 bio-based polyethylene to bring sustainability to its advanced turf technologies. The Poligras Paris GT zero, the world’s first carbon-zero synthetic hockey turf, was prominently featured during the Paris 2024 Olympic Games, setting a new benchmark for sustainable sports infrastructure. In football, the LigaTurf Cross GT zero system offers a fully recyclable and multifunctional turf solution that supports eco-friendly organic infills and meets elite performance standards – all while helping reduce carbon emissions.

bottle up & Eurobottle: reusable bottles made from I’m green^TM



 bio-based PE.

bottle up, based in Amsterdam, Netherlands, offers stylish, refillable bottles designed to reduce plastic waste and lower carbon emissions using renewable materials. Eurobottle, from Dronten, Netherlands, has over 30 years of experience producing durable, reusable sports bottles



-now completely bio-based to support a circular future.

Together, these partners show how everyday products can combine design, durability, and climate-friendly materials.

Veja: Veja, the French footwear and accessories brand, created a sneaker with internal layers, made with I’m green^TM



 bio-based materials. This product highlights how bio-based plastics can be seamlessly integrated into premium consumer products without compromising on design or performance.

Strategic partnerships

In collaboration with leading machine manufacturers, Braskem is leveraging strategic partnerships to demonstrate the performance of its polymers’ technologies across a variety of transformation processes. Live demonstrations at partner booths will showcase the practical application of these materials, emphasizing their role in driving innovation and sustainability within the industry. These partnerships underscore the importance of seamless integration between equipment, processing methods, and polymers portfolios. By aligning technological capabilities, Braskem and its partners are enabling more efficient, forward-thinking solutions tailored to the evolving needs of the market. It is possible to find Braskem’s polymers at Euro Machinery (Hall 11, I46), Dr. Boy (Hall 13, A43), and Carnevalli (Hall 16, C170).

Service – Braskem at the K 2025 Fair

Date: 8 to 15 October 2025

Booth location: Hall 6 – Stand D27

 

ABOUT BRASKEM

Braskem is a global, human-oriented petrochemical company with a forward-looking approach, cultivating strong relationships and generating value for all. Offering sustainable chemical and plastic solutions to improve people’s lives, the company has a comprehensive portfolio of plastic resins and chemical products for various sectors, including food packaging, construction, industrial, automotive, agribusiness, healthcare, and hygiene, among others. Braskem believes that disruptive innovation is the only path to establishing a new relationship with the planet. That’s why it chooses to act in the present, promoting plastic circularity and driving the revolution of bio-based materials. With 40 industrial units in Brazil, the U.S., Mexico, and Germany, the company exports its products to customers in over 70 countries through its 8,500 team members who operate globally under a management model that demonstrates a commitment to ethics, compliance with regulations in all countries, and respect for responsible comp

CAMBRIDGE, Mass., Oct. 9, 2025 /PRNewswire/ — Apnimed, Inc., a pharmaceutical company building the industry-leading portfolio of first-in-class oral drugs that address the root causes of obstructive sleep apnea (OSA) and other sleep-related breathing diseases, today announced that management will be participating in the 5^th Annual Needham Private Biotech and MedTech Company Virtual 1×1 Forum taking place October 14-15, 2025.

Apnimed will be hosting investor meetings virtually on Tuesday, October 14, and Wednesday, October 15.

About Apnimed
Apnimed is a privately held, clinical-stage pharmaceutical company based in Cambridge, Massachusetts, dedicated to transforming the treatment landscape for sleep-related breathing diseases. We believe the introduction of simple, once-nightly oral drugs may dramatically expand diagnosis and the reach of treatment for people with OSA. OSA, like other common chronic diseases such as diabetes or hypertension, would benefit from having multiple drugs with differing mechanisms to more fully address the heterogeneity of disease pathophysiology. Apnimed envisions a new era where novel oral therapies simplify intervention, expand the reach of diagnosis and treatment, and help more people get the oxygen and restorative sleep needed to thrive.

Apnimed is advancing a robust pipeline of oral pharmaceutical product candidates designed to improve oxygenation in individuals living with OSA and other chronic sleep-related breathing diseases. Our lead candidate, AD109, could become the catalyst for a new oral treatment paradigm for OSA that has been historically limited to cumbersome devices or invasive surgeries. Apnimed is also developing several therapies as part of its joint venture with Shionogi & Co., Ltd., Shionogi-Apnimed Sleep Science.

Learn more at apnimed.com or follow us on X and LinkedIn.

Media Contact:
[email protected]

Investor Contact:
[email protected]

SOURCE Apnimed, Inc.